ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Active pH Modulation by Proton Channel-Peptide Nucleic Acid Complex for Effective siRNA Endosomal Escape.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Small interfering RNA (siRNA) has shown great potential for treating various genetic diseases, but lysosomal degradation limits its bioavailability. Here, we present the design of a Channel-PNA-siRNA (CPR) complex that facilitates endosomal escape by actively inducing osmotic rupture of the endosomes. Our design utilizes the transmembrane domain of the M2 proton channel (M2TM) to facilitate proton influx into the liposome while serving as an anchor for siRNA; this surface tethering is mediated by a peptide nucleic acid (PNA) linker that enables stable, non-covalent binding. Our results indicate that the CPR complex interrupts the endosomal pathway, effectively reducing the colocalization of delivered siRNA with lysosomes and enhancing gene regulation efficiency. Furthermore, we demonstrate dual-target gene knockdown using CPR-tethered liposomes by encapsulating additional siRNAs in the empty cavity of the liposome. These findings highlight the therapeutic potential of modulating the endosomal pH environment to prevent lysosomal degradation, suggesting that the CPR nanocarrier design could serve as a versatile platform for targeted RNA delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.